Pink Lady in Emergency Medicine
In emergency medicine, "Pink Lady" refers to a mixture of viscous lidocaine and liquid antacid (usually Maalox) administered orally to patients with suspected esophageal pain or gastroesophageal reflux disease (GERD). This combination is used diagnostically and therapeutically in emergency departments, though it is not formally recommended in current guidelines.
Composition and Administration
- Pink Lady typically consists of equal parts viscous lidocaine (2%) and liquid antacid (usually Maalox or similar), creating a pink-colored solution 1
- The standard dose is typically 10-30 mL administered orally as a single dose 1
- The mixture gets its name from the characteristic pink color that results from combining these medications 1
Clinical Uses
- Used primarily in emergency departments as a diagnostic and therapeutic agent for patients presenting with:
- The antacid component neutralizes gastric acid, while the lidocaine provides local anesthesia to the esophageal mucosa 1
Limitations and Concerns
- Relief of symptoms after administration of Pink Lady is not a reliable diagnostic indicator of esophageal pathology 1
- There is limited high-quality evidence supporting its use as a diagnostic tool 1
- The anesthetic effect may mask symptoms without addressing the underlying cause 1
- Potential risks include:
Current Recommendations
- Pink Lady is not formally recommended in current emergency medicine guidelines for chest pain evaluation 1
- More definitive diagnostic approaches are preferred, such as:
Alternative Approaches
- For suspected GERD or esophageal pain, proton pump inhibitors or H2 blockers may provide relief without the risks associated with local anesthetics 1
- For patients with confirmed esophageal disorders, targeted therapy addressing the specific underlying condition is preferred 1
While Pink Lady remains in use in some emergency departments, clinicians should be aware of its limitations as both a diagnostic and therapeutic agent, and should not rely on it to rule out serious pathology.